The Deidesheimer Meeting: Significance of classical and new risk factors in Non-Insulin-Dependent Diabetes Mellitus

Journal of Diabetes and its Complications

Volumn 11, Issue 2, 1997, Pages 100-103

  Yudkin, John S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR;

ATHEROGENESIS; BLOOD FLOW; CORONARY RISK; DYSLIPIDEMIA; FIBRINOLYSIS; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MATERNAL NUTRITION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM;

EID: 0030895198     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(96)00094-3     Document Type: Article

References (31)

1. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall Study. BMJ 287:867-870, 1983.
2. Yudkin JS: How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. BMJ 306:1313-1318, 1993.
3. Jarrett RJ: Is insulin atherogenic? Diabetologia 31:71-75, 1988.
4. Despres J-P, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S and Lupien P-J: Hyperinsulinemia as an independent risk factor for ischemie heart disease. N Engl J Med 334:952-957, 1996.
5. Juhan-Vague I, Alessi MC, Vague P: Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 34:457-462, 1991.
6. Gray R, Yudkin J, Patterson D: Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: A role for plasminogen activator inhibitor? Br Heart J 70:530-536, 1993.
7. Gray RP, Yudkin JS, Patterson DLH: Plasminogen acti-vator inhibitor: a risk factor for myocardial infarction in diabetic subjects. Br Heart J 69:228-232, 1993.
8. Anfosso F, Chomiki N, Alessi C, Vague P, Juhan-Vague I: Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. J din Invest 91:2185-2193, 1993.
9. Schneider DJ, Nordt TK, Sobel BE: Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells. Diabetes 41:890-895; 1992.
10. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ et al.: Insulin deficiency in noninsulin-dependent diabetes. Lancet 1:293-295, 1989.
11. Nagi DK, Hendra T, Ryle AJ, Cooper TM, Temple RC, Clark PMS, et al.: The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulindependent) diabetic subjects. Diabetologia 33:532-537, 1990.
12. Mohamed-Ali V, Gould MM, Gillies S, Goubet S, Yudkin JS, Haines AP: Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects-evidence against a modulating role for insulin. Diabetologia 38:1110-1116, 1995.
13. Yudkin JS, Denver AE, Ramaiya K, Mohamed-Ali V, Goubet S, Gould M, Haines A: Elevated concentrations of proinsulin-like molecules are associated with coronary heart disease in non-diabetic subjects [Abstract]. Diabetes 44:(suppl 1)220, 1995.
14. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ: Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1:17-19, 1984.
15. Deckert T, Yokoyama H, Mathiesen E, Ronn B, Jensen T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen JS: Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BM] 312:871-874, 1996.
16. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet ii:530-533, 1988.
17. Yudkin JS. Microalbuminuria in non-diabetic individuals-a prognostic index of cardiovascular disease. International Yearbook Nephrol Dial Transplant 9:59-74, 1994.
18. Nosadini R, Cipollina MR, Solini A, et al.: Close relationship between microalbuminuria and insulin resistance in essential hypertension and non-insulin dependent diabetes mellitus. J Am Soc Nephrol 3:S56-S63, 1992.
19. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G: Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342:883-887, 1993.
20. Foyle W-J, Carstensen E, Fernandez M., Yudkin JS. A longitudinal study of associations of microalbuminuria with the insulin resistance syndrome and sodium-lithium countertransport in non-diabetic subjects. Arteriosder Thromb Vase Biol 15:1330-1337, 1995.
21. Bradford Hill A: The environment and disease: association or causation? Proc R Soc Med 58:295-300, 1965.
22. Hales CN, Barker DJP, Martyn CN: Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 46:595-601, 1992.
23. Barker DJP: Mothers, Babies, and Disease in Later Life. London, BMJ Publishing Group, 1994.
24. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS: Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62-67, 1993.
25. Stanner SA, Andres C, Poteen VV, Lantseva OE, Borodina VL, Yudkin JS: Glucose intolerance and dyslipidemia-related to intrauterine starvation? The Leningrad Siege Study [Abstract]. Diabetic Med 12:(suppl 2)S18, 1995.
26. Rizzo G, Arduini D: Fetal cardiac function in intrauterine growth retardation. Am J Obstet Gynecol 165:876-882, 1991.
27. Dahri S, Snoeck A, Reusens-Billen B, Remade C, Hoet JJ: Islet function in offspring of mothers on low-protein diet during gestation. Diabetes 40:(suppl 2)115-120, 1991.
28. Desai M, Crowther NJ, Ozanne SE, Lucas A, Hales CN: Adult glucose and lipid metabolism may be programmed during fetal life. Biochem Soc Trans 23:331-335, 1995.
29. Laakso M, Edleman SV, Brechtel G, Baron AD: Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 41:1076-1083, 1992.
30. Bergman RN, Yang YJ, Hope ID, Ader M: The role of transcapillary insulin transport in the efficiency of insulin action. Harm Metab Res 24:49-56, 1990.
31. Eckel RH: Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 320:1060-1068, 1989.